Cost-effectiveness of ovarian stimulation agents for IUI in couples with unexplained subfertility

STUDY QUESTION: Which agent for ovarian stimulation (OS) is the most cost-effective option in terms of net benefit for couples with unexplained subfertility undergoing IUI? SUMMARY ANSWER: In settings where a live birth is valued at €3000 or less, between €3000 and €55 000 and above €55 000, clomiph...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eekelen, R, Wang, R, Danhof, N A, Mol, F, Mochtar, M, Mol, B W, van Wely, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366296/
https://www.ncbi.nlm.nih.gov/pubmed/33615360
http://dx.doi.org/10.1093/humrep/deab013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366296/
https://www.ncbi.nlm.nih.gov/pubmed/33615360
http://dx.doi.org/10.1093/humrep/deab013

Ejemplares similares